stockrowSolventum Corporation
SOLV Healthcare Medical Instruments & Supplies
Solventum Corporation’s revenue for fiscal 2025 (year ended December 2025) was $8.3 billion, up 0.86% from fiscal 2024.
- Revenue
- −7.01%
- EPS
- −101.0%
- Free cash flow
- +561.9%
- Total debt
- −90.1%
Quarter to September 2026, against a year earlier
Follow SOLV
Alert me
Solventum Corporation (SOLV) Return on invested capital
Solventum Corporation's return on invested capital over the twelve months to 30 September 2026 was 0.00%, down 14.8 percentage points from fiscal 2025 (14.8%). That is below the Medical Instruments & Supplies industry median of 0.13% and in line with the Healthcare sector median of 0.00%.
Return on invested capital, annual
Embed this chart
Annual newest first
| Period | Return on invested capital | Change (points) |
|---|---|---|
| FY2025 | 14.8% | 8.47 |
| FY2024 | 6.34% | (2.88) |
| FY2023 | 9.22% | 9.22 |
| FY2022 | 0.00% | — |
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| WST West Pharmaceutical Services, Inc. compare | 18.0% |
| ALGN Align Technology, Inc. compare | 12.3% |
| ATR AptarGroup, Inc. compare | 7.83% |
| AVTR Avantor, Inc. compare | 3.36% |
| COO The Cooper Companies, Inc. compare | 3.17% |
| BLCO Bausch + Lomb Corporation compare | 2.16% |
| RGEN Repligen Corporation compare | 0.64% |
| SOLV Solventum Corporation | 0.00% |
| BAX Baxter International Inc. compare | −1.05% |
| Medical Instruments & Supplies industry median | 0.13% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)
More on SOLV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement